These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231 [TBL] [Abstract][Full Text] [Related]
7. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
8. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704 [TBL] [Abstract][Full Text] [Related]
9. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243 [TBL] [Abstract][Full Text] [Related]
13. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics. Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215 [TBL] [Abstract][Full Text] [Related]
14. Solitary Pulmonary Perivascular Epithelial Cell Tumor Mimicking Pulmonary Metastasis on 68 Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Liang S; Chen X Clin Nucl Med; 2024 Jun; 49(6):567-568. PubMed ID: 38631001 [TBL] [Abstract][Full Text] [Related]
15. 111In-DTPA-Octreotide SPECT (OctreoScan) Uptake in Metastatic Renal Cell Carcinoma to the Pancreas. Chan K; Luong TV; Navalkissoor S Clin Nucl Med; 2018 Jan; 43(1):e29-e30. PubMed ID: 29166326 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865 [TBL] [Abstract][Full Text] [Related]
17. Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation. Kuyumcu S; Özkan ZG; Sanli Y; Yilmaz E; Mudun A; Adalet I; Unal S Ann Nucl Med; 2013 Jul; 27(6):538-45. PubMed ID: 23543506 [TBL] [Abstract][Full Text] [Related]
18. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome. Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400 [TBL] [Abstract][Full Text] [Related]
19. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma. Chen EJ; Tan TH; Chew MT; Chye PC Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702 [TBL] [Abstract][Full Text] [Related]
20. 68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver. Nisar MU; Costa DN; Jia L; Öz OK; de Blanche L Clin Nucl Med; 2021 Aug; 46(8):e428-e430. PubMed ID: 34034323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]